<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Ambu A/S

    Ambu A/S

    Ambu A/S engages in the development, production, and marketing of diagnostic and l...

    Ambu A/S engages in the development, production...

    Filing Type:    PU
    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals, Inc

    CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in ...

    CNS Pharmaceuticals is a pre-clinical stage bio...

    Amount Raised:    $628,558
    Fundraising Status:    EC
    Filing Type:    CF
    Neuralstem, Inc.

    Neuralstem, Inc.

    Neuralstem is a biopharmaceutical company developing novel treatments for nervous ...

    Neuralstem is a biopharmaceutical company devel...

    Filing Type:    PU
    Aerpio Pharmaceuticals, Inc.

    Aerpio Pharmaceuticals, Inc.

    Aerpio Pharmaceuticals is a biopharmaceutical company focused on advancing first-i...

    Aerpio Pharmaceuticals is a biopharmaceutical c...

    Filing Type:    PU
    iRadimed Corporation

    iRadimed Corporation

    IRADIMED CORPORATION is a leader in the development of innovative magnetic resonan...

    IRADIMED CORPORATION is a leader in the develop...

    Filing Type:    PU
    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow is here to change the way we think about artificial limbs. They...

    Unlimited Tomorrow is here to change the way we...

    Amount Raised:    $883,964.00
    Fundraising Status:    EC
    Filing Type:    CF
    Shionogi & Co. Ltd.

    Shionogi & Co. Ltd.

    Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, an...

    Shionogi & Co., Ltd. engages in the research, d...

    Filing Type:    PU
    Neuronetics, Inc.

    Neuronetics, Inc.

    Neuronetics, Inc. is focused on designing, developing, and marketing products that...

    Neuronetics, Inc. is focused on designing, deve...

    Filing Type:    PU
    Fisher Wallace Laboratories, Inc.

    Fisher Wallace Laboratories, Inc.

    Fisher Wallace manufactures and markets wearable medical devices for the treatment...

    Fisher Wallace manufactures and markets wearabl...

    Amount Raised:    $670,653.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.